News
16h
Zacks Investment Research on MSNVale to Report Q1 Earnings: What's in Store for the Stock?Vale S.A. VALE is expected to report a decline in its bottom and top lines when it reports first-quarter 2025 results on ...
14h
Zacks Investment Research on MSNDover Gears Up to Report Q1 Earnings: What to Expect From the Stock?Dover Corporation DOV is set to release first-quarter 2025 results on April 24, before the opening bell. The Zacks Consensus ...
Agnico Eagle's disciplined approach to M&A and exploration success has led to consistent reserve growth and per share growth.
Equities research analysts at Zacks Research reduced their FY2025 earnings per share (EPS) estimates for Catalyst Pharmaceuticals in a research note issued to investors on Wednesday, March 19th.
The consensus estimate for Huntsman’s current full-year earnings is $0.32 per share. Zacks Research also issued estimates for Huntsman’s FY2025 earnings at $0.03 EPS, Q1 2026 earnings at $0.04 ...
While earnings per share missed estimates ... billion and improved 2.1% from the year-ago fiscal quarter’s reported figure. Quarterly earnings were hurt by the challenging conditions prevalent ...
The consensus mark for earnings has moved down by a penny in the past 30 days to 87 cents per share, indicating a decline of 27.5% from the year-ago quarter’s reported figure. LW has a trailing ...
Despite a lower price-to-earnings ratio and attractive dividend yield, ONE Gas's stock performance has been disappointing. Learn more about OGS stock here.
Analysts expect the company to report earnings per share of five cents in the fourth ... Net sales per customer will also be a key metric. This figure was up 4.2% to $567 in the third quarter ...
Earnings-per-share came in at $2.15 ... well above the expected $57.9 billion figure. Alphabet Q3 earnings 2024 Third-quarter earnings beat estimates, sending shares surging after the closing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results